You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 27, 2024

CLINICAL TRIALS PROFILE FOR DEXTROSE 5% AND LACTATED RINGER'S


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Dextrose 5% And Lactated Ringer's

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00113685 ↗ Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury Completed National Heart, Lung, and Blood Institute (NHLBI) N/A 2003-04-01 The purpose of this study is to evaluate the clinical outcome of patients following blunt traumatic injury with hypovolemic shock, who receive either lactated ringer's solution or hypertonic saline with dextran (HSD) resuscitation; also, to focus specifically on neurologic outcome in patients with brain injury and on the effect of HSD resuscitation on inflammatory cell responsiveness.
NCT00113685 ↗ Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury Completed University of Washington N/A 2003-04-01 The purpose of this study is to evaluate the clinical outcome of patients following blunt traumatic injury with hypovolemic shock, who receive either lactated ringer's solution or hypertonic saline with dextran (HSD) resuscitation; also, to focus specifically on neurologic outcome in patients with brain injury and on the effect of HSD resuscitation on inflammatory cell responsiveness.
NCT00181077 ↗ Hypertonic Saline Use in Preeclampsia Completed Johns Hopkins University Phase 1 2003-06-01 To compare hypertonic saline to Lactated Ringer's solution and assess whether one speeds up the process of getting rid of extra body water faster in women with preeclampsia.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Dextrose 5% And Lactated Ringer's

Condition Name

Condition Name for Dextrose 5% And Lactated Ringer's
Intervention Trials
Anesthesia 5
Cesarean Section 4
Hypotension 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Dextrose 5% And Lactated Ringer's
Intervention Trials
Hypotension 16
Pancreatitis 11
Hemorrhage 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Dextrose 5% And Lactated Ringer's

Trials by Country

Trials by Country for Dextrose 5% And Lactated Ringer's
Location Trials
Egypt 37
United States 33
China 12
Korea, Republic of 5
Saudi Arabia 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Dextrose 5% And Lactated Ringer's
Location Trials
Illinois 4
Pennsylvania 3
Connecticut 3
California 3
Minnesota 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Dextrose 5% And Lactated Ringer's

Clinical Trial Phase

Clinical Trial Phase for Dextrose 5% And Lactated Ringer's
Clinical Trial Phase Trials
Phase 4 39
Phase 3 14
Phase 2/Phase 3 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Dextrose 5% And Lactated Ringer's
Clinical Trial Phase Trials
Completed 64
Not yet recruiting 29
Recruiting 26
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Dextrose 5% And Lactated Ringer's

Sponsor Name

Sponsor Name for Dextrose 5% And Lactated Ringer's
Sponsor Trials
Ain Shams University 9
Cairo University 6
Mansoura University 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Dextrose 5% And Lactated Ringer's
Sponsor Trials
Other 214
Industry 17
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.